Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephanie Dizier is active.

Publication


Featured researches published by Stephanie Dizier.


PLOS ONE | 2015

Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies

Stephanie Dizier; Jean-Marie Forel; Louis Ayzac; Jean-Christophe Richard; Sami Hraiech; Samuel Lehingue; Anderson Loundou; Antoine Roch; Claude Guérin; Laurent Papazian; Acurasys study investigators

Introduction Bilirubin is well-recognized marker of hepatic dysfunction in intensive care unit (ICU) patients. Multiple organ failure often complicates acute respiratory distress syndrome (ARDS) evolution and is associated with high mortality. The effect of early hepatic dysfunction on ARDS mortality has been poorly investigated. We evaluated the incidence and the prognostic significance of increased serum bilirubin levels in the initial phase of ARDS. Methods The data of 805 patients with ARDS were retrospectively analysed. This population was extracted from two recent multicenter, prospective and randomised trials. Patients presenting with ARDS with a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen < 150 mmHg measured with a PEEP ≥ 5 cm of water were included. The total serum bilirubin was measured at inclusion and at days 2, 4, 7 and 14. The primary objective was to analyse the bilirubin at inclusion according to the 90-day mortality rate. Results The 90-day mortality rate was 33.8% (n = 272). The non-survivors were older, had higher Sepsis-related Organ Failure Assessment (SOFA) score and were more likely to have a medical diagnosis on admission than the survivors. At inclusion, the SOFA score without the liver score (10.3±2.9 vs. 9.0±3.0, p<0.0001) and the serum bilirubin levels (36.1±57.0 vs. 20.5±31.5 μmol/L, p<0.0001) were significantly higher in the non-survivors than in the survivors. Age, the hepatic SOFA score, the coagulation SOFA score, the arterial pH level, and the plateau pressure were independently associated with 90-day mortality in patients with ARDS. Conclusion Bilirubin used as a surrogate marker of hepatic dysfunction and measured early in the course of ARDS was associated with the 90-day mortality rate.


Intensive Care Medicine | 2014

Comparison of femorofemoral and femorojugular configurations during venovenous extracorporeal membrane oxygenation for severe ARDS

Christophe Guervilly; Stephanie Dizier; Guillemette Thomas; Nicolas Jaussaud; Pierre Morera; Sami Hraiech; Fanny Klazen; Jean-Marie Forel; Mélanie Adda; Antoine Roch; Frédéric Collart; Laurent Papazian

Dear Editor, Schmidt et al. [1] recently demonstrated that an extracorporeal membrane oxygenation (ECMO) flow greater than 60 % of cardiac output was always associated with an SaO2 greater than 90 % during venovenous ECMO (vvECMO) for severe ARDS. We postulate that the configuration of the circuit may affect arterial oxygenation. We performed a retrospective comparative study of the medical charts of the patients according to ECMO configuration. During the oldest period, cannulation was performed with a femorofemoral (FF) configuration according to the experience of the ANZIC group [2], whereas during the latest period femorojugular (FJ) configuration was preferred. Details about the cannulas and the ECMO circuit’s components are available in previous publications [3, 4]. Nine patients with FF were compared with nine with FJ configuration (Table 1). In the case of the FF configuration, the drainage cannulation was inserted via the left femoral vein with the tip located at the junction between the iliac vein and the inferior vena cava, and the infusion cannula was inserted via the right femoral vein with the tip located at the junction between the right atrium and the inferior vena cava. In the case of the FJ configuration, the drainage cannula was inserted via the right femoral vein with the tip located at the junction


Annals of Intensive Care | 2013

Pharmacological interventions in acute respiratory distress syndrome

Antoine Roch; Sami Hraiech; Stephanie Dizier; Laurent Papazian

Pharmacological interventions are commonly considered in acute respiratory distress syndrome (ARDS) patients. Inhaled nitric oxide (iNO) and neuromuscular blockers (NMBs) are used in patients with severe hypoxemia. No outcome benefit has been observed with the systematic use of iNO. However, a sometimes important improvement in oxygenation can occur shortly after starting administration. Therefore, its ease of use and its good tolerance justify iNO optionally combined with almitirne as a rescue therapy on a trial basis. Recent data from the literature support the use of a 48-h infusion of NMBs in patients with a PaO2 to FiO2 ratio <120 mmHg. No strong evidence exists on the increase of ICU-acquired paresis after a short course of NMBs. Fluid management with the goal to obtain zero fluid balance in ARDS patients without shock or renal failure significantly increases the number of days without mechanical ventilation. On the other hand, patients with hemodynamic failure must receive early and adapted fluid resuscitation. Liberal and conservative fluid strategies therefore are complementary and should ideally follow each other in time in the same patient whose hemodynamic state progressively stabilizes. At present, albumin treatment does not appear to be justified for limitation of pulmonary edema and respiratory morbidity. Aerosolized β2-agonists do not improve outcome in patients with ARDS and one study strongly suggests that intravenous salbutamol may worsen outcome in those patients. The early use of high doses of corticosteroids for the prevention of ARDS in septic shock patients or in patients with confirmed ARDS significantly reduced the duration of mechanical ventilation but had no effect or even increased mortality. In patients with persistent ARDS after 7 to 28 days, a randomized trial showed no reduction in mortality with moderate doses of corticosteroids but an increased PaO2 to FiO2 ratio and thoracopulmonary compliance were found, as well as shorter durations of mechanical ventilation and of ICU stay. Conflicting data exist on the interest of low doses of corticosteroids (200 mg/day of hydrocortisone) in ARDS patients. In the context of a persistent ARDS with histological proof of fibroproliferation, a corticosteroid treatment with a progressive decrease of doses can be proposed.


PLOS ONE | 2013

Time to Intubation Is Associated with Outcome in Patients with Community-Acquired Pneumonia

Sami Hraiech; Julie Alingrin; Stephanie Dizier; Julie Brunet; Jean-Marie Forel; Bernard La Scola; Antoine Roch; Laurent Papazian; Vanessa Pauly

Introduction It has been suggested that delayed intensive care unit (ICU) transfer is associated with increased mortality for patients with community-acquired pneumonia (CAP). However, ICU admission policies and patient epidemiology vary widely across the world depending on local hospital practices and organizational constraints. We hypothesized that the time from the onset of CAP symptoms to invasive mechanical ventilation could be a relevant prognostic factor. Methods One hundred patients with a CAP and necessitating invasive mechanical ventilation were included. Prospectively collected data were retrospectively analysed. Two study groups were identified based on the time of the initiation of invasive mechanical ventilation (rapid respiratory failure requiring mechanical ventilation within 72 h of the onset of CAP and progressive respiratory failure requiring invasive mechanical ventilation 4 or more days after the onset of CAP). Results Excepting more COPD patients in the rapid respiratory failure group and more patients with diabetes in the progressive respiratory failure group, these patients had similar characteristics. The overall in-hospital mortality rate was 28% in the rapid respiratory failure group and 51% in the progressive respiratory failure group (P = 0.03). The ICU and the day 30 mortality rates were higher in the progressive respiratory failure group (47% vs. 23%, P = 0.02; and 37.7% vs. 21.3%, P = 0.03; respectively). After adjusting for the propensity score and other potential confounding factors, progressive respiratory failure remained associated with hospital mortality only after 12 days of invasive mechanical ventilation. Conclusions This study suggested that the duration or delay in the time to intubation from the onset of CAP symptoms was associated with the outcomes in those patients who ultimately required invasive mechanical ventilation.


Clinics in Chest Medicine | 2014

The Use of Paralytics in Patients with Acute Respiratory Distress Syndrome

Sami Hraiech; Stephanie Dizier; Laurent Papazian

Interest in the role of neuromuscular blocking agents (NMBAs) in the treatment of acute respiratory distress syndrome (ARDS) has been renewed since a recent randomized clinical trial showed a reduction in mortality associated with the use of NMBAs. However, the role of paralytics in a protective mechanical ventilation strategy should be detailed. This review summarizes data in the literature concerning the clinical effects of NMBAs on the outcome of patients with ARDS, in an attempt to explain some pathophysiologic hypotheses concerning their action and to integrate them into the overall management strategy for the mechanical ventilation of ARDS patients.


Journal of Thoracic Disease | 2018

Single-lung and double-lung transplantation: technique and tips

Lucile Gust; Xavier-Benoit D’Journo; Geoffrey Brioude; Delphine Trousse; Stephanie Dizier; Christophe Doddoli; Marc Leone

The first successful single-lung and double-lung transplantations were performed in the eighties. Since then both surgical and anesthesiological management have improved. The aim of this paper is to describe the surgical technique of lung transplantation: from the anesthesiological preparation, to the explantation and implantation of the lung grafts, and the preparation of the donor lungs. We will also describe the main surgical complications after lung transplantation and their management. Each step of the surgical procedure will be illustrated with photos and videos.


Revue des Maladies Respiratoires Actualités | 2017

Stratégie chirurgicale : quelles nouvelles techniques ? La chirurgie minimalement invasive (RATS/VATS). Les exérèses d’épargne parenchymateuse. Les parcours de soin accélérés

Lucile Gust; G. Brioude; N. Ghourchidian; Stephanie Dizier; Aude Charvet; D. Trousse; Xavier Benoit D’Journo; C. Doddoli; Marc Leone

Resume La chirurgie thoracique a beneficie de nombreuses innovations techniques au cours des dernieres decennies. En parallele les programmes de depistage permettent de diagnostiquer des cancers bronchiques primitifs a des stades plus precoces. Les pratiques chirurgicales se sont donc modifiees d’une part par la generalisation des voies mini-invasives, d’autre part par l’apparition des resections anatomiques infralobaires (segmentectomies) que l’on pourraient qualifier de « chirurgie de precision » qui apparaissent comme des alternatives valables a la lobectomie dans des situations definies, et enfin par la mise en place de parcours de soins acceleres et personnalises, parfois meme ambulatoires. L’objet de cette revue, sera de detailler ces aspects modernes de la chirurgie thoracique au travers de ces trois points, intrinsequement lies les uns aux autres.


Intensive Care Medicine | 2014

Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center.

Antoine Roch; Sami Hraiech; Elodie Masson; Dominique Grisoli; Jean-Marie Forel; Mohamed Boucekine; Pierre Morera; Christophe Guervilly; Mélanie Adda; Stephanie Dizier; Richard Toesca; Frédéric Collart; Laurent Papazian


Intensive Care Medicine | 2010

Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study.

Antoine Roch; Renaud Lepaul-Ercole; Dominique Grisoli; Jacques Bessereau; Olivier Brissy; Matthias Castanier; Stephanie Dizier; Jean-Marie Forel; Christophe Guervilly; Vlad Gariboldi; Frédéric Collart; Pierre Michelet; Gilles Perrin; Remi Charrel; Laurent Papazian


Intensive Care Medicine | 2015

Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation

Jean-Marie Forel; Christophe Guervilly; Sami Hraiech; François Voillet; Guillemette Thomas; Claude Somma; Véronique Secq; Catherine Farnarier; Marie-Josée Payan; Stéphanie-Yannis Donati; Gilles Perrin; Delphine Trousse; Stephanie Dizier; L. Chiche; Karine Baumstarck; Antoine Roch; Laurent Papazian

Collaboration


Dive into the Stephanie Dizier's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antoine Roch

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marc Leone

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar

Sami Hraiech

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lucile Gust

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aude Charvet

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge